TY - JOUR
T1 - The psychometric properties of the Leicester Cough Questionnaire and Respiratory Symptoms in CF tool in cystic fibrosis
T2 - A preliminary study
AU - Ward, Nathan
AU - Stiller, Kathy
AU - Rowe, Hilary
AU - Holland, Anne E.
PY - 2017/5/1
Y1 - 2017/5/1
N2 - Background There are few tools to quantify the impact of cough in cystic fibrosis (CF). The psychometric properties of the Leicester Cough Questionnaire (LCQ) and Respiratory Symptoms in CF (ReS-CF) tool were investigated in adults with CF. Methods Validity and reliability were assessed in clinically stable participants who completed the questionnaires twice, along with the Cystic Fibrosis Questionnaire – Revised (CFQ-R). Responsiveness was assessed by change in questionnaires following treatment for an acute respiratory exacerbation. Results Correlations between the LCQ and CFQ-R respiratory domain were moderate (n = 59, rs = 0.78, p < 0.001). Correlations between ReS-CF and CFQ-R respiratory domain were fair (rs = − 0.50, p < 0.001). The LCQ total score was repeatable (ICC 0.92, 95%CI 0.87–0.96, n = 50). In those reporting improvement in symptoms following treatment (n = 36), LCQ total score had a mean change of 4.6 (SD 3.7) and effect size of 1.2. Conclusions The LCQ and ReS-CF appear to be valid, reliable and responsive in CF. Trial Registration: www.anzctr.org.au: ACTRN12615000262505
AB - Background There are few tools to quantify the impact of cough in cystic fibrosis (CF). The psychometric properties of the Leicester Cough Questionnaire (LCQ) and Respiratory Symptoms in CF (ReS-CF) tool were investigated in adults with CF. Methods Validity and reliability were assessed in clinically stable participants who completed the questionnaires twice, along with the Cystic Fibrosis Questionnaire – Revised (CFQ-R). Responsiveness was assessed by change in questionnaires following treatment for an acute respiratory exacerbation. Results Correlations between the LCQ and CFQ-R respiratory domain were moderate (n = 59, rs = 0.78, p < 0.001). Correlations between ReS-CF and CFQ-R respiratory domain were fair (rs = − 0.50, p < 0.001). The LCQ total score was repeatable (ICC 0.92, 95%CI 0.87–0.96, n = 50). In those reporting improvement in symptoms following treatment (n = 36), LCQ total score had a mean change of 4.6 (SD 3.7) and effect size of 1.2. Conclusions The LCQ and ReS-CF appear to be valid, reliable and responsive in CF. Trial Registration: www.anzctr.org.au: ACTRN12615000262505
KW - Cough
KW - Cystic fibrosis
KW - Leicester Cough Questionnaire
KW - Signs and symptoms, respiratory
KW - Surveys and questionnaires
UR - http://www.scopus.com/inward/record.url?scp=85008196704&partnerID=8YFLogxK
U2 - 10.1016/j.jcf.2016.11.011
DO - 10.1016/j.jcf.2016.11.011
M3 - Article
C2 - 27986494
AN - SCOPUS:85008196704
SN - 1569-1993
VL - 16
SP - 425
EP - 432
JO - Journal of Cystic Fibrosis
JF - Journal of Cystic Fibrosis
IS - 3
ER -